AM Investment Strategies’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420K Buy
7,289
+15
+0.2% +$861 0.08% 81
2026
Q1
$441K Buy
7,274
+16
+0.2% +$933 0.1% 77
2025
Q4
$391K Buy
7,258
+2,269
+45% +$109K 0.08% 86
2025
Q3
$225K Sell
4,989
-11,915
-70% -$556K 0.05% 101
2025
Q2
$782K Sell
16,904
-69,156
-80% -$3.39M 0.18% 60
2025
Q1
$5.25M Buy
86,060
+933
+1% +$54.4K 1.27% 17
2024
Q4
$4.82M Buy
85,127
+75
+0.1% +$4.19K 1.17% 16
2024
Q3
$4.4M Buy
85,052
+6,960
+9% +$326K 1.07% 18
2024
Q2
$3.24M Buy
78,092
+11,743
+18% +$525K 0.8% 20
2024
Q1
$3.6M Buy
66,349
+924
+1% +$47.1K 0.91% 20
2023
Q4
$3.36M Buy
65,425
+642
+1% +$33.7K 0.95% 20
2023
Q3
$3.76M Sell
64,783
-2,508
-4% -$154K 1.22% 18
2023
Q2
$4.34M Sell
67,291
-158
-0.2% -$10.6K 1.36% 13
2023
Q1
$4.67M Sell
67,449
-15
-0% -$1.06K 1.6% 11
2022
Q4
$4.85M Buy
67,464
+50
+0.1% +$3.77K 1.73% 11
2022
Q3
$4.79M Sell
67,414
-2,035
-3% -$148K 1.76% 9
2022
Q2
$5.35M Sell
69,449
-1,583
-2% -$121K 1.87% 9
2022
Q1
$5.19M Sell
71,032
-273
-0.4% -$18.3K 1.37% 16
2021
Q4
$4.45M Buy
71,305
+6,055
+9% +$355K 1.07% 19
2021
Q3
$3.86M Buy
65,250
+337
+0.5% +$22.2K 1.01% 19
2021
Q2
$4.34M Sell
64,913
-46
-0.1% -$3K 1.12% 16
2021
Q1
$4.1M Buy
64,959
+355
+0.5% +$22.1K 1.14% 16
2020
Q4
$4.01M Buy
64,604
+4,278
+7% +$263K 1.23% 16
2020
Q3
$3.64M Buy
+60,326
New +$3.63M 1.28% 14

Other funds holding BMY

AM Investment Strategies's BMY Position: Q2 2026 in Review

AM Investment Strategies increased its Bristol-Myers Squibb (BMY) stake by 0.21% in Q2 2026, buying an estimated $861 and bringing the position to 7,289 shares worth $420K. The position accounts for 0.08% of the portfolio, ranked #81.

AM Investment Strategies first reported a position in BMY in Q3 2020 and has held it in 24 quarters since. The position peaked at $5.35M in Q2 2022. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • AM Investment Strategies held 7,289 shares of Bristol-Myers Squibb worth $420K as of Q2 2026.
  • AM Investment Strategies bought 15 Bristol-Myers Squibb shares in Q2 2026, an estimated $861.
  • Bristol-Myers Squibb made up 0.08% of AM Investment Strategies's portfolio in Q2 2026, its #81 holding.
  • AM Investment Strategies first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 24 quarters since.
  • AM Investment Strategies's Bristol-Myers Squibb position peaked at $5.35M in Q2 2022.
  • 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on AM Investment Strategies's 13F filing for Q2 2026, filed 16 Jul 2026.